APOE and Alzheimer disease: Relative to its low-risk common isoform ApoE3, ApoE4 molecule is marked with a Cys-to-Arg-112 replacement, and homozygous APOE4 brings about a 65% lifetime risk estimate to develop AD by age 85 [94,95].